The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study evaluating the safety and tolerability of durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer.
 
Chrystal Ann Landry
No Relationships to Disclose
 
Jeannette Marcelle Guziel
No Relationships to Disclose
 
Meng Ru
No Relationships to Disclose
 
Charles L. Shapiro
No Relationships to Disclose
 
Julie Fasano
Consulting or Advisory Role - Magellan Health
 
Aarti Sonia Bhardwaj
No Relationships to Disclose
 
Hanna Irie
No Relationships to Disclose
 
Nina Bhardwaj
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Genentech
Speakers' Bureau - CPSciences; CureVac; Inception Sciences; Neon Therapeutics
Research Funding - Merck
 
Amy Tiersten
Honoraria - Amgen; Tesaro
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Amgen; tesaro
Research Funding - AstraZeneca; pfizer
Travel, Accommodations, Expenses - Amgen; tesaro